Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
lupus nephritis
Biotech
Cullinan rebrands, halts lymphoma trial in autoimmune refocus
Cullinan Therapeutics, as the biotech will now be known, is switching the focus of its CD19xCD3 T-cell engager to lupus.
James Waldron
Apr 16, 2024 10:05am
Equillium delivers new lupus data to Ono's doorstep
Apr 1, 2024 10:53am
After hunt for buyer fails, Aurinia lays off 25%, drops R&D
Feb 15, 2024 8:25am
Kyverna overshoots raised IPO expectations with $319M offering
Feb 8, 2024 8:24am
Lupus Therapeutics, AbbVie partner for trials of SLE therapy
Oct 26, 2023 9:00am
Kezar offloads 41% of staff, CEO to keep lupus candidate affloat
Oct 4, 2023 7:40am